Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Becton Dickinson and Co (NYSE:BDX)

166.71
Delayed Data
As of Jun 24
 -5.48 / -3.18%
Today’s Change
128.87
Today|||52-Week Range
171.64
+8.19%
Year-to-Date
Strong And Under The Radar: Becton Dickinson (BDX)
Jun 21 / TheStreet.com - Paid Partner Content
Becton, Dickinson (BDX) Inks Partnership Deal with CAPS
Jun 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close172.19
Today’s open168.90
Day’s range166.25 - 169.73
Volume1,464,129
Average volume (3 months)955,873
Market cap$36.1B
Dividend yield1.58%
Data as of 4:01pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-44.07%
Earnings growth (this year)+19.67%
Earnings growth (next 5 years)+11.25%
Revenue growth (last year)+21.94%
P/E ratio44.6
Price/Sales2.68
Price/Book5.00

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...-0.60-2.61%
SYKStryker Corp-1.79-1.51%
ZBHZimmer Biomet Holdin...-4.23-3.50%
EWEdwards Lifesciences...-3.04-3.07%
Data as of 4:04pm ET, 06/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$2.21
Annual revenue (last year)$10.3B
Annual profit (last year)$695.0M
Net profit margin6.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
Chief Financial Officer &
EVP-Administration
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts

Partner Offers

Search for Jobs